CYP3A5 polymorphism in kidney transplantation: individualizing tacrolimus dosing

被引：0
|
作者：
Pasari, Amit S. [1 ,2 ]
Balwani, Manish R. [1 ,2 ]
Bawankule, Charulata [1 ,2 ]
Sejpal, Kapil [1 ]
Gurjar, Prasad [1 ]
Kashiv, Pranjal [1 ]
Dubey, Shubham [1 ]
Malde, Sunny [1 ]
Gupta, Sushrut [1 ]
Pawar, Twinkle [1 ]
机构：
[1] JNMC, Nephrol, Wardha, India
[2] Saraswati Kidney Care Ctr, Nephrol, Nagpur, Maharashtra, India
来源：
TRANSPLANTATION | 2024年 / 108卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
302.4
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [31] Study on the regularity between CYP3A5/3A4 polymorphism in medication of tacrolimus after renal transplantation
    Guo, Yuan-yuan
    Jiang, Wen-tao
    Shen, Zhong-yang
    Zhang, Yi
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 37 - 37
  • [32] Study on the regularity between CYP3A5/3A4 polymorphism in medication of tacrolimus after renal transplantation
    Acta Pharmacologica Sinica, 2013, 34 (Suppl 1) : S37 - S42
  • [33] Impact of CYP3A5 Genetic Polymorphism on Intrapatient Variability of Tacrolimus Exposure in Chinese Kidney Transplant Recipients
    Cheung, Chi Yuen
    Chan, Koon Ming
    Wong, Yuen Ting
    Chak, Wai Leung
    Bekers, Otto
    van Hooff, Johannes P.
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (06) : 1754 - 1757
  • [34] Influence of CYP3A5 Polymorphism in Donor and Recipient on Tacrolimus Pharmacokinetics and Clinical Outcome after Renal Transplantation
    Cauffiez, Christelle
    Glowacki, Francois
    Lionet, Arnaud
    Provot, Francois
    Hazzan, Marc
    Noel, Christian
    Allorge, Delphine
    Broly, Franck
    THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 661 - 661
  • [35] INFLUENCE OF CYP3A5 POLYMORPHISM IN DONOR AND RECIPIENT ON TACROLIMUS PHARMACOKINETICS AND CLINICAL OUTCOME AFTER RENAL TRANSPLANTATION
    Cauffiez, Christelle
    Glowacki, Francois
    Lionet, Arnaud
    Provot, Francois
    Hazzan, Marc
    Noel, Christian
    Broly, Franck
    TRANSPLANT INTERNATIONAL, 2009, 22 : 174 - 174
  • [36] Impact of Cyp 3a5 Genotype on Lcp Tacrolimus Dosing and Monitoring in Kidney Transplantation.
    Taber, D. J.
    Carcella, T.
    Patel, N.
    Bartlett, F.
    Posadas, A.
    Rao, V.
    Casey, M.
    Rohan, V.
    Dubay, D.
    Taber, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 562 - 562
  • [37] THE ROLE OF CYP3A5 GENOTYPE AND TACROLIMUS MONITORING IN STABLE KIDNEY TRANSPLANTATIONS
    Baraldo, Massimo
    Adani, Gian Luigi
    Righi, Elda
    Tulissi, Patrizia
    Vallone, Clotilde
    Baccarani, Umberto
    Damante, Giuseppe
    Risaliti, Andrea
    Montanaro, Domenico
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [38] Influence of CYP3A5 and ABCB1 Polymorphism on Tacrolimus Drug Dosing in South Indian Renal Allograft Recipients
    Fernando, M. Edwin
    Sellappan, Manokaran
    Prasad, N. D. Srinivasa
    Suren, Sujit
    Thirumalvalavan, K.
    INDIAN JOURNAL OF NEPHROLOGY, 2019, 29 (04) : 261 - 266
  • [39] ASSOCIATION BETWEEN TACROLIMUS AND CYP3A5 GENOTYPE IN PEDIATRIC KIDNEY TRANSPLANT
    Alghamdi, A.
    Lazear, D.
    Varnell, C.
    Seay, S.
    Hooper, D.
    Darland, L.
    Mizuno, T.
    Ramsey, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S10 - S10
  • [40] Influence of tacrolimus CYP3A5 polymorphisms on the dose-level response after pediatric kidney transplantation
    Alvarez Elias, Ana Catalina
    Garcia-Roca, Pilar
    Velasquez-Jones, Luis
    Valverde-Rosas, Saul
    Varela-Fascinetto, Gustavo
    Medeiros, Mara
    PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2321 - 2321
12345